Australian scientists say a recent vitamin E therapy may improve prostate cancer survival rates.
Illustration. (Internet source)
Dr Patrick Ling and colleagues from the Queensland University of Technology in Australia have found a special constituent molecule in the vitamin E tocotrienol (T3) that successfully destroys prostate cancer cells. is the cause of cancer recurrence in patients after surgery, radiotherapy and chemotherapy.
The study was published in the International Journal of Cancer last week.
Dr. Ling said: ' There is currently no effective treatment for metastatic prostate cancer because it develops again after the patient has undergone conventional treatments for more. 70% of patients.
However, with gamma-tocotrienol, researchers at Queensland University of Technology have found a better way to treat the disease . '
Ling and colleagues acceded to animal tests whereby mice experimenting with prostate cancer cells were fed gamma-tocotrienol with water.
As a result, 70% of experimental mice were resistant to tumor formation and significantly reduced the risk of recurrence for the rest. In contrast, 100% of the mice that were intolerant to these substances appeared tumors.